MedTrace Logo

Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome

NCT05343858 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-05-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of the consumption of two microalgae Chlorella vulgaris and Arthrospira platensis (Spirulina) on some biomarkers of metabolic syndrome: Total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, Apolipoprotein A and Apolipoprotein B, in overweight / obese subjects with altered lipid profile.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Experimental: Group 1: Spirulina platensis

16 g/day (two doses of 8g)

DIETARY_SUPPLEMENT

Experimental: Group 2: Chlorella vulgaris

16 g/day (two doses of 8g)

DIETARY_SUPPLEMENT

Placebo Comparator: Group 3: Control

16 g/day (two doses of 8g)

Sponsors & Collaborators

  • AlgaEnergy, S.A.

    collaborator UNKNOWN

  • Instituto de Investigación Hospital Universitario La Paz

    lead OTHER

Principal Investigators

  • Carmen Gómez-Candela · La Paz University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-09
Primary Completion
2019-10-09
Completion
2021-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05343858 on ClinicalTrials.gov